BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 25733077)

  • 1. Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?
    Rutka M; Milassin Á; Szepes Z; SzŰcs M; Nyári T; Bálint A; Bor R; Molnár T; Farkas K
    Scand J Gastroenterol; 2015 Aug; 50(8):985-90. PubMed ID: 25733077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of endoscopic indices in the determination of disease activity in patients with ulcerative colitis.
    Kucharski M; Karczewski J; Mańkowska-Wierzbicka D; Karmelita-Katulska K; Grzymisławski M; Kaczmarek E; Iwanik K; Rzymski P; Swora-Cwynar E; Linke K; Dobrowolska A
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):722-30. PubMed ID: 26894632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings.
    Iacucci M; Fort Gasia M; Hassan C; Panaccione R; Kaplan GG; Ghosh S; Gui X
    Endoscopy; 2015 Aug; 47(8):726-34. PubMed ID: 25826276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
    Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
    Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
    Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
    J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
    Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
    Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
    Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
    J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.
    Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S
    J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
    Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
    Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.
    Lobatón T; Bessissow T; De Hertogh G; Lemmens B; Maedler C; Van Assche G; Vermeire S; Bisschops R; Rutgeerts P; Bitton A; Afif W; Marcus V; Ferrante M
    J Crohns Colitis; 2015 Oct; 9(10):846-52. PubMed ID: 26116558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission.
    Arai M; Naganuma M; Sugimoto S; Kiyohara H; Ono K; Mori K; Saigusa K; Nanki K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Matsuoka K; Inoue N; Ogata H; Iwao Y; Kanai T
    J Crohns Colitis; 2016 Nov; 10(11):1303-1309. PubMed ID: 27194529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.